Hodgkin Lymphoma | Oncology Today with Dr Neil Love: Hodgkin Lymphoma Edition

published 2 weeks ago by Dr Neil Love

Featuring a discussion on recent advances in the treatment of Hodgkin lymphoma with Dr Craig Moskowitz, including the following topics: Hodgkin lymphoma 2020: What are the important questions in up-front therapy? — Craig Moskowitz, MD (00:00) Case: A woman in her early 20s with relapsed/refractory Stage IV classical Hodgkin lymphoma (HL) receives pembrolizumab/gemcitabine/vinorelbine/doxorubicin (21:48) Case: A man in his early 20s with primary refractory Stage IV HL attains a complete response with brentuximab vedotin (BV) and nivolumab (25:04) Case: A woman in her early 30s with newly diagnosed Stage IIIA classical HL is enrolled on the Phase III SWOG-S1826 trial evaluating AVD (doxorubicin/vinblastine/dacarbazine) in combination with BV or nivolumab (30:56) CME information and select publications

more episodes from Research To Practice | Oncology Videos